Class-III: Clinical Performance of Glass-hybrid in the Treatment of Class III Restorations

Sponsor
Hacettepe University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05843734
Collaborator
(none)
50
2
2
35
25
0.7

Study Details

Study Description

Brief Summary

This is a double blinded, split mouth, randomized clinical study that evaluated the performance of a glass hybrid restorative material in class III lesions. The lesions will be restored with glass hybrid restorative (Equia Forte) or anterior composite resin (G-aenial Anterior). Restorations will be evaluated after 24 months according to FDI criteria and the data will be analyzed.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Equia forte HT
N/A

Detailed Description

The aim of this study was to comparatively evaluate the clinical performance of a glass-hybrid-restorative with an anterior composite resin (G-aenial Anterior) in class III lesions.

Participants who are 18 years of age or older and healthy, and who have applied to the Restorative Dentistry Department of Hacettepe University Faculty of Dentistry to receive treatment for class III lesions on their front teeth will be included in the study. After explaining the purpose and conditions of the study, they will be asked to sign an informed consent form. The gender, age, and tooth numbers of the participants to be treated will be recorded. 100 upper incisors of 50 patients will be treated, with attention paid to the balanced distribution of teeth in the right and left arches. The "split-mouth" model will be used in the study, with two teeth included in one mouth and each restorative material placed in one tooth. The restorative material to be placed on the teeth will be determined randomly. Before starting the restoration, papers with the names of both materials will be placed in envelopes, and then the assistant staff will be asked to randomly select one of the envelopes during the restoration stage to provide randomization.Data were will be analyzed with Chi- Square, Fisher's Exact Test, Mann U tests

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Clinical Performance of Glass Hybrid Restorations in the Treatment of Class III Lesions: A Randomized Clinical Trial
Actual Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Dec 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Equia forte HT (glass-hybrid) group

This study planned to investigate the clinical performance of Equia Forte HT (permanent glass hybrid restorative) in the treatment of anterior class III restorations. This arm of the study is the group whose effectiveness was investigated. The results will be evaluated by comparing with a traditional anterior resin composite in terms of functional, biological and aesthetic properties.

Procedure: Equia forte HT
Restoration of anterior class III caries lesions
Other Names:
  • G-Aenial anterior
  • Active Comparator: "G-Aenial anterior"

    This group will serve as a "control". Equia forte HT (glass-hybrid) restorations will compare with the "G-Aenial anterior" anterior resin composite restorations.

    Procedure: Equia forte HT
    Restoration of anterior class III caries lesions
    Other Names:
  • G-Aenial anterior
  • Outcome Measures

    Primary Outcome Measures

    1. Functional properties [2 years]

      The primary factor for determining the clinical performance of a restorative material is the Functional properties. Visual tactile examination tools will be used for evaluating restorations according to FDI criteria by two experienced researchers at 1- week 6-, 12-, 18- and 24- months. The functional properties are scored as 1- clinically excellent, 2-clinically good, 3-clinically sufficient/satisfactory, 4-clinically unsatisfactory 5-clinically poor (replacement necesessry). Clinically 1, 2 and 3 scores are clinical acceptable but 4 and 5 scores are designated as failure.

    2. Esthetic properties [2 years]

      Second outcome is esthetic properties. The secondary factor for determining the clinical performance of a restorative material is the Esthetic properties. Visual examination will be used for evaluating restorations according to FDI criteria by two experienced researchers at 1- week 6-, 12-, 18- and 24- months. The Esthetic properties are scored as 1- clinically excellent, 2-clinically good, 3-clinically sufficient/satisfactory, 4-clinically unsatisfactory 5-clinically poor (replacement necesessry). Clinically 1, 2 and 3 scores are clinical acceptable but 4 and 5 scores are designated as failure.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • The participant must be at least 18 years of age or older

    • The participant has at least two class III lesions and the lesions are in symmetrical teeth located in the right and left arch

    • The lesion covers at most 2/3 and at least 1/3 of the dentin

    • Participant voluntarily signing the informed consent form

    • The participant does not have a physical disability that may prevent them from coming to the control.

    • Absence of a periapical pathology in the involved tooth

    Exclusion Criteria:
    • Having systemic disorders that may prevent the participant from regularly attending treatment and control appointments.

    • Having severe periodontal problems in the tooth planned to be treated

    • Absence of the opposite of the tooth and not participating in chewing

    • Lesions which is limited with the enamel tissue

    • Teeth with lesions that are too large to be restored

    • Patients with anterior malocclusion

    • Patients with parafunctional habits.

    • Mentally disabled patients.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hacettepe University School of Dentistry Ankara Turkey 06100
    2 Hacettepe University Ankara Turkey 06100

    Sponsors and Collaborators

    • Hacettepe University

    Investigators

    • Principal Investigator: UZAY KoƧ VURAL, PhD.DDS, Hacettepe

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Uzay Koc, Assoc. Prof., Hacettepe University
    ClinicalTrials.gov Identifier:
    NCT05843734
    Other Study ID Numbers:
    • 2022/12-03
    First Posted:
    May 6, 2023
    Last Update Posted:
    May 6, 2023
    Last Verified:
    May 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Uzay Koc, Assoc. Prof., Hacettepe University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 6, 2023